Guided Therapeutics (GTHP) Dividend Coverage Ratio (2023 - 2024)
Guided Therapeutics' (GTHP) quarterly Dividend Coverage Ratio came in at 3.67 in Q1 2024, up 54.49% year-over-year from 2.38 in Q2 2023, and down 112.55% quarter-over-quarter from 29.26 in Q2 2023.
Powered by 
Analysis
Guided Therapeutics (GTHP) Dividend Coverage Ratio (2023 - 2024) Analysis & Trends
Guided Therapeutics has disclosed Dividend Coverage Ratio across 2 years of filings, most recently posting 3.67 for Q1 2024.
- In Q1 2024, Dividend Coverage Ratio rose 54.49% year-over-year to 3.67; the TTM figure through Jun 2024 stood at 19.86 (up 76.36% YoY), while the FY2023 annual figure was 57.57, down 39.08% from the prior year.
- Dividend Coverage Ratio came in at 3.67 for Q1 2024 at Guided Therapeutics, down from 29.26 in the prior quarter.
- In the past five years, Dividend Coverage Ratio ranged from a high of 29.26 in Q2 2023 to a low of 8.07 in Q1 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Div. Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 0.84 |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 1.61 |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 3.79 |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | - |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | - |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 3.27 |
| 10 | Guided Therapeutics | 24.13 Mn | 24.12 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2024 | -3.67 |
| Jun 30, 2023 | 29.26 |
| Mar 31, 2023 | -8.07 |